Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,755Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Iressa

02 2Iressa

PharmaCompass

01

Brand Name : Iressa

Gefitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Iressa

arrow
Pharmtech & Ingredients
Not Confirmed

Gefitinib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 268

2019 Revenue in Millions : 423

Growth (%) : -37

blank

02

Brand Name : Iressa

Gefitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Iressa

arrow
Pharmtech & Ingredients
Not Confirmed

Gefitinib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 183

2020 Revenue in Millions : 268

Growth (%) : -32

blank

03

Brand Name : Iressa

Gefitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Iressa

arrow
Pharmtech & Ingredients
Not Confirmed

Gefitinib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 114

2021 Revenue in Millions : 183

Growth (%) : -38

blank

04

Brand Name : Iressa

Gefitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Iressa

arrow
Pharmtech & Ingredients
Not Confirmed

Gefitinib

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 623

2014 Revenue in Millions : 543

Growth (%) : -13%

blank

05

Brand Name : Iressa

Gefitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Iressa

arrow
Pharmtech & Ingredients
Not Confirmed

Gefitinib

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 528

2016 Revenue in Millions : 513

Growth (%) : 3

blank

06

Brand Name : Iressa

Gefitinib

arrow
Pharmtech & Ingredients
Not Confirmed

07

Brand Name : Iressa

Gefitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Iressa

arrow
Pharmtech & Ingredients
Not Confirmed

Gefitinib

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 518

2017 Revenue in Millions : 528

Growth (%) : -2%

blank

08

Brand Name : Iressa

Gefitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Iressa

arrow
Pharmtech & Ingredients
Not Confirmed

Gefitinib

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 513

2015 Revenue in Millions : 543

Growth (%) : -6

blank

09

Brand Name : Iressa

Gefitinib

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Iressa

arrow
Pharmtech & Ingredients
Not Confirmed

Gefitinib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 423

2018 Revenue in Millions : 518

Growth (%) : -18

blank